XML 16 R25.htm IDEA: XBRL DOCUMENT v3.19.3
Acquisition (Tables)
 9 Months Ended
Sep. 30, 2019
Business Combinations [Abstract]  
Schedule of Business Acquisitions by Acquisition, Equity Interest Issued or Issuable The acquisition date fair value of common stock transferred is calculated below (in thousands, except share and per share amounts):
Common Stock ValuationAmount
Shares of common stock issued as consideration1,000,000  
Stock price per share on closing date$13.94  
Value of common stock issued as consideration$13,940  
Issue discount due to lack of marketability$(697) 
Fair value of common stock at December 10, 2018$13,243  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed The Company is in the process of completing its valuation of certain assets and liabilities, primarily related to accounts receivable and accounts payable assumed; thus, the provisional measurements of current assets and current liabilities are subject to change.
December 10, 2018
(As Initially Reported)		Measurement Period and Other AdjustmentsDecember 10, 2018
(As Adjusted)
Current assets$22,172  $2,257  $24,429  
Property and equipment21,029  (428) 20,601  
Identifiable intangible assets71,792  (3,463) 68,329  
Goodwill50,873  679  51,552  
Long-term assets170  —  170  
Total assets acquired$166,036  $(955) $165,081  
Current liabilities(10,769) (892) (11,661) 
Long-term liabilities (1)(15,265) 282  (14,983) 
Net assets acquired$140,002  $(1,565) $138,437  
(1) Includes $14.7 million and $12.9 million as initially reported and as adjusted, respectively, in deferred tax liabilities associated with tangible and intangible assets acquired.
Business Acquisition, Pro Forma Information
The following unaudited pro forma information (in thousands) have been provided for illustrative purposes only and are not necessarily indicative of results that would have occurred had the acquisition of Genoptix occurred on January 1, 2018, nor are they necessarily indicative of future results.

Nine Months Ended September 30, 2018
Revenue$274,609  
Net loss$(1,164) 
Net income available to common shareholders$2,284